Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 10/01/17
End: 06/01/20
Due: 06/01/21
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 09/30/15
End: 09/30/19
Due: 09/30/20
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO) | NCT03259009 | Association des Gastroentérologues Oncologues | user2@example.com | None | 2017-10-01 | 2020-06-01 | 2021-06-01 | - | - | 2025-07-14 |
| RAS Mutation Testing in the Circulating Blood of Patients With Metastatic Colorectal Cancer | NCT02502656 | Association des Gastroentérologues Oncologues | user2@example.com | None | 2015-07-31 | 2017-08-31 | 2018-08-31 | - | - | 2025-07-14 |
| Prognostic and Predictive Impact of Circulating Tumor DNA in Gastric Cancer Treatment | NCT02674373 | Association des Gastroentérologues Oncologues | user2@example.com | None | 2015-09-30 | 2019-09-30 | 2020-09-30 | - | - | 2025-07-14 |